Medicis Pharmaceutical (MRX)

[Investorman]

Zack's.com 1/29/2003

Medicis Pharmaceutical Corporation (NYSE:MRX) is an independent pharmaceutical company focusing exclusively on the treatment of dermatological conditions. Medicis offers prescription, over-the-counter and physician-dispensed dermatology products. The company has a solid stable of core brands that performed extremely well in the second quarter of fiscal 2003. In that quarter, MRX reported earnings of 55 cents per diluted share on net revenues of $59.5 million. The earnings result surpassed the year-ago total of 47 cents while revenue improved from $53 million. MRX said that it remains focused on expanding sales of its core brands, while pursuing interesting business development opportunities and supplementing its research and development pipeline with additional therapies to benefit to its universe of physicians.